Wei Pan, Weihong Tang, Zhongmin Wang, Yunyun Deng, Shan Ye
{"title":"Correlation study of JAK2-STAT3 signaling pathway and CD4 + T lymphocyte subset changes in CMPA children.","authors":"Wei Pan, Weihong Tang, Zhongmin Wang, Yunyun Deng, Shan Ye","doi":"10.1177/09287329251360089","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundCow's milk protein allergy (CMPA) is a common food allergy in children, affecting growth, development, and quality of life. The pathogenesis involves immune dysregulation, particularly CD4+ T lymphocyte subsets, which play a key role in immune responses. The JAK2-STAT3 signaling pathway is critical for immune cell regulation, but its role in CMPA-associated immune changes remains unclear.MethodsA total of 103 CMPA patients and 100 healthy controls were enrolled. Peripheral blood samples were collected from patients before and after a 3-month CMPA avoidance diet. Flow cytometry, ELISA, western blotting, and qRT-PCR were used to analyze CD4+ T cell subsets (Th1, Th2, Th17), cytokine levels, and JAK2-STAT3 pathway activity.ResultsCMPA patients exhibited increased Th2 and Th17 proportions and reduced Th1 cells compared to controls. JAK2 and STAT3 phosphorylation levels were elevated, while SOCS1/SOCS3 expression was downregulated. After dietary avoidance, Th2 and Th17 proportions decreased, Th1 increased, and JAK2-STAT3 activation normalized. Pearson correlation analysis revealed positive associations between JAK2-STAT3 activation and Th2/Th17 proportions and a negative correlation with Th1.ConclusionsThe JAK2-STAT3 signaling pathway is abnormally activated in CMPA and correlates with CD4+ T lymphocyte subset imbalances. Targeting this pathway may offer therapeutic potential for CMPA management.</p>","PeriodicalId":48978,"journal":{"name":"Technology and Health Care","volume":" ","pages":"9287329251360089"},"PeriodicalIF":1.4000,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Technology and Health Care","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1177/09287329251360089","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
BackgroundCow's milk protein allergy (CMPA) is a common food allergy in children, affecting growth, development, and quality of life. The pathogenesis involves immune dysregulation, particularly CD4+ T lymphocyte subsets, which play a key role in immune responses. The JAK2-STAT3 signaling pathway is critical for immune cell regulation, but its role in CMPA-associated immune changes remains unclear.MethodsA total of 103 CMPA patients and 100 healthy controls were enrolled. Peripheral blood samples were collected from patients before and after a 3-month CMPA avoidance diet. Flow cytometry, ELISA, western blotting, and qRT-PCR were used to analyze CD4+ T cell subsets (Th1, Th2, Th17), cytokine levels, and JAK2-STAT3 pathway activity.ResultsCMPA patients exhibited increased Th2 and Th17 proportions and reduced Th1 cells compared to controls. JAK2 and STAT3 phosphorylation levels were elevated, while SOCS1/SOCS3 expression was downregulated. After dietary avoidance, Th2 and Th17 proportions decreased, Th1 increased, and JAK2-STAT3 activation normalized. Pearson correlation analysis revealed positive associations between JAK2-STAT3 activation and Th2/Th17 proportions and a negative correlation with Th1.ConclusionsThe JAK2-STAT3 signaling pathway is abnormally activated in CMPA and correlates with CD4+ T lymphocyte subset imbalances. Targeting this pathway may offer therapeutic potential for CMPA management.
期刊介绍:
Technology and Health Care is intended to serve as a forum for the presentation of original articles and technical notes, observing rigorous scientific standards. Furthermore, upon invitation, reviews, tutorials, discussion papers and minisymposia are featured. The main focus of THC is related to the overlapping areas of engineering and medicine. The following types of contributions are considered:
1.Original articles: New concepts, procedures and devices associated with the use of technology in medical research and clinical practice are presented to a readership with a widespread background in engineering and/or medicine. In particular, the clinical benefit deriving from the application of engineering methods and devices in clinical medicine should be demonstrated. Typically, full length original contributions have a length of 4000 words, thereby taking duly into account figures and tables.
2.Technical Notes and Short Communications: Technical Notes relate to novel technical developments with relevance for clinical medicine. In Short Communications, clinical applications are shortly described. 3.Both Technical Notes and Short Communications typically have a length of 1500 words.
Reviews and Tutorials (upon invitation only): Tutorial and educational articles for persons with a primarily medical background on principles of engineering with particular significance for biomedical applications and vice versa are presented. The Editorial Board is responsible for the selection of topics.
4.Minisymposia (upon invitation only): Under the leadership of a Special Editor, controversial or important issues relating to health care are highlighted and discussed by various authors.
5.Letters to the Editors: Discussions or short statements (not indexed).